Advertisement
Canadian Journal of Cardiology

COVID-19, Inflammatory Heart Disease, and Vaccination in the Athlete and Highly Active Person: An Update and Further Considerations

      Members of the Community and Athletic Cardiovascular Health Network (CATCHNet) and the writing group for the Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes provided previous guidance on the cardiovascular return-to-play (RTP) recommendations for athletes and highly active persons following COVID-19 infection.
      • McKinney J.
      • Connelly K.A.
      • Dorian P.
      • et al.
      COVID-19 myocarditis and return to play: reflections and recommendations from a Canadian Working Group.
      A significant accumulation of evidence has occurred, and the pandemic has evolved with new variants and the availability of highly effective vaccinations. This document aims to provide an update to these previous recommendations for the sports clinician regarding cardiovascular RTP and new guidance on vaccination.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McKinney J.
        • Connelly K.A.
        • Dorian P.
        • et al.
        COVID-19 myocarditis and return to play: reflections and recommendations from a Canadian Working Group.
        Can J Cardiol. 2021; 37: 1165-1174
        • Gluckman T.J.
        • Bhave N.M.
        • Allen L.A.
        • et al.
        2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-COV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee.
        J Am Coll Cardiol. 2022; 79: 1717-1756
        • Ferreira V.M.
        • Schulz-Menger J.
        • Holmvang G.
        • et al.
        Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations.
        J Am Coll Cardiol. 2018; 72: 3158-3176
        • Petek B.J.
        • Moulson N.
        • Baggish A.L.
        • et al.
        for the ORCCA Investigators. Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS-CoV-2 infection in 3597 collegiate athletes: a study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA).
        Br J Sports Med. 2021; https://doi.org/10.1136/bjsports-2021-104644
        • Oster M.E.
        • Shay D.K.
        • Su J.R.
        • et al.
        Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021.
        JAMA. 2022; 327: 331-340